Also in a mouse glioblastoma model, an inhibitor of M-CSFR significantly increased survival and regressed established tumor, which was in this case not due to TAM depletion, but rather to a decreased expression of M2 markers and an unopposed production of anti-tumoral GM-CSF and IFNγ (104). The gene discussed is IFNG; the disease is neoplasm.